Reconstruction of intestinal microecology of Type 2 diabetes by fecal microbiota transplantation: Why and how

  • Kaijian Hou Department of Endocrine and Metabolic Diseases, Longhu Hospital, The First Affiliated Hospital of Medical College of Shantou University, Shantou, Guangdong, China ;Shantou University Medical College, Shantou University, Shantou, Guangdong, China
  • Shuo Zhang Department of Endocrine and Metabolic Diseases, Longhu Hospital, The First Affiliated Hospital of Medical College of Shantou University, Shantou, Guangdong, China ;Shantou University Medical College, Shantou University, Shantou, Guangdong, China
  • Zezhen Wu Department of Endocrine and Metabolic Diseases, Longhu Hospital, The First Affiliated Hospital of Medical College of Shantou University, Shantou, Guangdong, China ;Shantou University Medical College, Shantou University, Shantou, Guangdong, China
  • Dan Zhu Department of Endocrine and Metabolic Diseases, Longhu Hospital, The First Affiliated Hospital of Medical College of Shantou University, Shantou, Guangdong, China
  • Fengwu Chen Department of Endocrine and Metabolic Diseases, Longhu Hospital, The First Affiliated Hospital of Medical College of Shantou University, Shantou, Guangdong, China
  • Zi-Ning Lei Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York, USA
  • Weiting Liu College of Nursing, Anhui University of Chinese Medicine, Hefei, Anhui, China
  • Chuanxing Xiao College of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China
  • Zhe-Sheng Chen Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St John’s University, Queens, NY 11439, USA https://orcid.org/0000-0002-8289-097X
Keywords: Fecal Microbiota Transplantation, Type 2 diabetes, intestinal microecology

Abstract

Type 2 diabetes (T2D) is a chronic metabolic disease characterized by hyperglycemia due to insulin resistance. Mounting evidence has correlated T2D to alterations in the composition of gut microbiota. Accordingly, targeting the gut microbiota has become an emerging strategy for T2D management. The aim of this article is to get a better insight into the rationale for targeting gut microbiota in T2D treatment. Thus, we herein reviewed the change of gut microbiota composition in T2D, factors shaping gut microbiota, and potential mechanisms behind the contribution of gut microbiota to T2D pathogenesis. At present, it has become possible to use intestinal microorganism capsules, bacteria liquid, and other preparations to carry out fecal microbiota transplantation for the treatment and intervention of T2D with insulin resistance and immune-mediated Type 1 diabetes (T1D).

Downloads

Download data is not yet available.
Published
2021-11-09
How to Cite
1.
Hou K, Zhang S, Wu Z, Zhu D, Chen F, Lei Z-N, Liu W, Xiao C, Chen Z-S. Reconstruction of intestinal microecology of Type 2 diabetes by fecal microbiota transplantation: Why and how. Bosn J of Basic Med Sci [Internet]. 2021Nov.9 [cited 2021Dec.6];. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/6323
Section
Reviews